GeneNews, a molecular diagnostics firm based in Toronto, hopes to obtain $7.8 million in a private offering of its company stock. The company is in talks to expand the reach of its ColonSentry blood-based assay for colon cancer stratification, which is currently available in New York and New Jersey, across the rest of the U.S., President and CEO Gailina Liew said.

Related Summaries